quinoxalines has been researched along with Night Blindness in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bower, KS; Burka, JM; Edwards, JD; Rabin, JC; Sediq, DA; Stutzman, RD | 1 |
| Choe, CM; Lee, ES; Lee, JH; You, YS | 1 |
2 other study(ies) available for quinoxalines and Night Blindness
| Article | Year |
|---|---|
Effect of brimonidine tartrate 0.15% on night-vision difficulty and contrast testing after refractive surgery.
Topics: Adrenergic alpha-Agonists; Adult; Brimonidine Tartrate; Contrast Sensitivity; Humans; Keratomileusis, Laser In Situ; Lasers, Excimer; Male; Middle Aged; Military Personnel; Night Blindness; Ophthalmic Solutions; Photorefractive Keratectomy; Postoperative Complications; Prospective Studies; Pupil; Quinoxalines; Surveys and Questionnaires; Visual Acuity | 2008 |
Efficacy of brimonidine tartrate 0.2% ophthalmic solution in reducing halos after laser in situ keratomileusis.
Topics: Adrenergic alpha-Agonists; Adult; Brimonidine Tartrate; Female; Humans; Keratomileusis, Laser In Situ; Lasers, Excimer; Light; Male; Night Blindness; Ophthalmic Solutions; Postoperative Complications; Postoperative Period; Pupil; Quinoxalines; Treatment Outcome | 2008 |